BridgeMD
New treatment option for Lymphedema
Official title The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related Lymphedema
ClinicalTrials.gov ID: NCT06532955
What this study is testing
- What it's testing
- This study assesses the performance of robot-assisted microsurgery. Lymphaticovenous anastomosis (LVA) is the most difficult procedure in microsurgery at this moment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Female gender;
- Treated for primary early stage breast cancer;
- Early stage lymphedema of the arm (stage 1 or 2 on ISL classification);
- ELV \> 10%;
- Suffering from unilateral disease.
You likely can't join if
- Male gender;
- Stage 3 lymphedema of the arm;
- Receiving current breast cancer treatment;
- Distant breast cancer metastases;
- Current substance abuse;
- History of marcaine or indocyanine green allergy;
See the full eligibility criteria
- Female gender;
- Treated for primary early stage breast cancer;
- Early stage lymphedema of the arm (stage 1 or 2 on ISL classification);
- ELV \> 10%;
- Suffering from unilateral disease.
- Male gender;
- Stage 3 lymphedema of the arm;
- Receiving current breast cancer treatment;
- Distant breast cancer metastases;
- Current substance abuse;
- History of marcaine or indocyanine green allergy;
- Non-viable lymphatic system as determined by near infrared imaging;
- Previous LVA (\<10 years) in the arm with lymphedema.
The study team makes the final eligibility decision.
Where it's taking place
- Maastricht, Limburg, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maastricht, Limburg, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.